← Eichor
Condition: Recurrent Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors
Phase 1/Phase 2 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06503094Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Y
Phase 2 · 2 location(s) · Min-Tze LIONG · NCT07297966Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Phase 2 · 1 location(s) · KTH Biopharma · NCT07698886A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic
Phase 1 · 8 location(s) · Autolus Limited · NCT06173518Alternative Prophylaxis in Female Recurrent Urinary Tract Infections
Phase 4 · 2 location(s) · University Hospital, Basel, Switzerland · NCT04095572Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Beva
Phase 3 · 32 location(s) · Genelux Corporation · NCT05281471Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07683104FMT Capsules for rCDI
Phase 3 · 1 location(s) · Helsinki University Central Hospital · NCT07458984Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or I
Phase N/A · 2 location(s) · Cardioangiologisches Centrum Bethanien · NCT06650826Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study
Phase 4 · 3 location(s) · Baylor College of Medicine · NCT07508124Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Phase 1/Phase 2 · 19 location(s) · Cellectis S.A. · NCT04150497Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
NA · 1 location(s) · Krunal Patel · NCT03562741AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
Phase 1 · 1 location(s) · Stanford University · NCT06340737A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relap
Phase 1 · 8 location(s) · Shanghai Pharmaceutical Group Biological Therapy Technology · NCT06927466Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL
Phase 1/Phase 2 · 1 location(s) · Kara Yakhteh Tajhiz Azma Company · NCT06635330Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
Phase 1/Phase 2 · 1 location(s) · University of California, San Diego · NCT06409819Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Phase 1/Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT01371630UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL
Phase 1/Phase 2 · 1 location(s) · University of Colorado, Denver · NCT04544592ML-Based ABPA Recurrence Prediction and Clinical Utility
Phase N/A · 1 location(s) · Qianfoshan Hospital · NCT07714863Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
Phase 3 · 8 location(s) · Kaohsiung Veterans General Hospital. · NCT06727864Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence
Phase 2 · 1 location(s) · Sano Chemicals Inc · NCT07521137An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Pat
Phase 1 · 1 location(s) · University of Minnesota · NCT06692179Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
Phase N/A · 2 location(s) · Jahn Ferenc South Pest Teaching Hospital · NCT06719232Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection
Phase 1 · 1 location(s) · University of Minnesota · NCT06370884COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
NA · 1 location(s) · Peking Union Medical College Hospital · NCT06168032Immunity Markers in Intensive Care Patients and Ventilator-associated Pneumonia
Phase N/A · 1 location(s) · Centre Hospitalier Intercommunal Aix-Pertuis · NCT06607055Recurrence of H Pylori : Incidence and Influential Factors.
NA · 1 location(s) · Sohag University · NCT07045857Prevention With Ismigen of RTIs in Kids
Phase 4 · 10 location(s) · Lallemand Pharma AG · NCT07578012
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.